| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |